Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Core Insights - Klotho Neurosciences, Inc. is focused on developing Klotho-based therapeutics aimed at treating neurodegenerative diseases [1] - The company's CEO and Chairman, Dr. Joseph Sinkule, will participate in the Inaugural Klotho Conference & Scientific Seminar [1] Company Overview - Klotho Neurosciences, Inc. is listed on NASDAQ under the ticker KLTO [1] - The company specializes in biotechnology with a specific emphasis on neurodegenerative disease treatments [1]